A 32 year old Gay man is admitted with a three month history of weight loss, fatigue, intermittent fever and lymphadenopathy. One month ago he developed.

Slides:



Advertisements
Similar presentations
Chest Infections Lawrence Pike.
Advertisements

Treatment and Prevention of Opportunistic Infections: Options for the Caribbean Region Excerpted from presentation by Jonathan E. Kaplan, M.D.
Review of HIV and Opportunistic Infections (OI) in Children
Global Health Case Studies – HIV and Tuberculosis Clinical Pearls in Diagnosis and Management Michael Tuggy, MD.
Tuberculosis and perinatal period Kai Kliiman Tartu University Lung Clinic Estonian NTP 15 September 2006 Tallinn.
STAGING OF HIV INFECTION, COMMON AND OPPORTUNISTIC INFECTIONS
18/10/ Mostafavi SN. MD Pediatric infectious disease departement Isfahan University of Medical Science 18/10/13902.
Ois generalPCPCryptococcus-Toxoplasma
Presented by: Samantha Todd & Sandra Thorbus
Judicious Antibiotic Use in Developing Countries Global Missions Health Conference Louisville, KY Nov. 9, 2012 Ron Herman, Ph.D.
Prof. Dr. Bilun Gemicioğlu
Pneumonia Why do we need to know about it? Long recognized as a major cause of death, Pneumonia has been studied intensively since late 1800s. Despite.
Pneumonia: nursing management Islamic University Nursing College.
Community- acquired Pneumonia Author Dr. Shek Kam Chuen Oct 2013 HKCEM College Tutorial.
Training on Clinical Care of HIV, AIDS and Opportunistic Infections Unit 7: Respiratory Conditions.
Severe pneumonia in childhood. Robert Gie Department Paediatrics and Child Health Stellenbosch University.
HIV Associated Opportunistic Infections in Ethiopia Daniel Fekade MD, MSc Faculty of Medicine, Addis Ababa University.
بنام خداوند جان وخرد. Dr. Alireza Emami Naeini Associate Prof. Department of Infectious Diseases Isfahan University of Medical Sciences(IUMS) Empiric.
A Case of IRIS Edward L. Goodman, MD October 8, 2003.
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Pneumocystis jiroveci Pneumonia Slide Set Prepared.
In the name of God Fariba Rezaeetalab Assistant Professor.
Fungal Infections Who is at Risk Seriously ill patients being treated with Corticosteroids Antineoplastic drugs Immunosuppressive drugs Patients with.
Late presenters and opportunistic infections Jane Bruton Clinical Research Nurse Imperial College.
Chronic HIV Infection Clinical Manifestations Opportunistic Infections O.I. Prophylaxis.
CASE 1 55 yo man…Baker HIV+ since 1996 Refused bloodwork over the years as was ‘Feeling fine’ Oral hairy leukoplakia noted on oral biopsy in 2001.
Affordable healthcare Product Selection for Opportunistic Infections IDA HIV/AIDS Group, Nienke Gruppelaar “ HIV does not kill, opportunistic infections.
1 Respiratory Diseases in HIV-infected Patients HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Unit 7 Treatment of TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Pulmonary Complications in HIV
HIV related Opportunistic Diseases HIV related Opportunistic Diseases M.MEIDANI,MPH.MD.
1 Guidance on Cotrimoxazole Prophylactic Therapy for HIV Exposed/Infected Children HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Two Men with Extensive Genital Ulcer Disease Recent Cases at the Denver Metro Health Clinic.
1 Starting ART in the Context of Opportunistic Infections HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Infections in the Immunocompromised Hail M. Al-Abdely, MD Consultant, Infectious Diseases King Faisal Specialist Hospital and Research Centre.
1 Overview of Opportunistic Infections in HIV/AIDS HAIVN Harvard Medical School AIDS Initiative in Vietnam.
NYU Medical Grand Rounds Clinical Vignette Lisa Cioce MD, PGY-2 March 10, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
PEDIATRIC MEDICATION CALCULATIONS
Pneumonia in Immunocompromised Host:- Pneumonia in an immunocompromised host describes a lung infection that occurs in a person whose ability to fight.
Bacterial Pneumonia.
Clinicopathologic Conference Advanced Update in HIV Medicine and Clinical Research October 1, 2009 Tammy M. Meyers, BA, MBBCh (WITS), FCPaed (SA), Mmed,
Connie van Marrewijk IDA Foundation Product Selection for Opportunistic Infections.
Clinical Case #25 Yvonne Josephine Banarez Pharmacology -A- October 12, 2006.
HIV/AIDS. Human Immunodeficiency Virus  Virus attacks the immune system  Invades and destroys certain white blood cells  Takes time for the HIV to.
1 HIV Clinical Staging HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Introduction to the diagnosis and management of common opportunistic infections (Ols) Module 4 Sub module OIs.
Prophylaxis of Opportunistic Infections
NYU Medical Grand Rounds Clinical Vignette Benjamin Eckhardt, MD PGY-3 October 6, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Questions, Answers, and Explanations Infectious Diseases Blueprint.
HIV D S O’Briain March Pathology of HIV Epidemic disease Influenza pandemic Legionnaire’s disease 1976 HIV 1981 Heroin, Dublin 2000 SARS.
Chapter 5: The Medical Side of Living with HIV/AIDS.
Therapeutics 3 Tutoring Exam 4 February 20 th, 2016 Lisa Hayes
Treatment and Prevention of Opportunistic Infections: Options for the Caribbean Region Jonathan E. Kaplan, M.D.
Therapeutics 3 Tutoring Exam 4 February 27 th, 2016 Lisa Hayes
Welcome To Presentation w Subject :Pharmaceutical Microbiology -1 w Topic: Pneumonia
Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, National Institutes of Health, and HIV Medicine Association/Infectious.
Endocarditis: Treatment
Bachar Samra MD1, Jacques Azzi MD1, Ambreen Khalil MD2.
Management of Urinary Tract Infections Renal Block
Management of Urinary Tract Infections Renal Block
Common Infectious Disease
HIV Opportunistic infections
AIDS Dr. Amitabha Basu MD.
Case studies in OI management
PCP in adults: Presentation , Treatment and Prophylaxis
Pneumocystis carinii Pneumonia
PCP in adults: Presentation , Treatment and Prophylaxis
Meningitis.
MANAGEMENT OF PCP Dr. Akaninyene A. Otu, MBBCh, DTM&H, MPH, MRCP (UK), FWACP University of Calabar Teaching Hospital Calabar, Nigeria.
Dr Immaculate Kariuki Consultant Paediatrician Nairobi, Kenya
Chest radiograph showing extensive bilateral interstitial infiltrates with ground glass shadowing. Chest radiograph showing extensive bilateral interstitial.
Presentation transcript:

A 32 year old Gay man is admitted with a three month history of weight loss, fatigue, intermittent fever and lymphadenopathy. One month ago he developed progressively increasing diarrhea and had experienced severe shortness of breath and a non productive cough for three days. His chest X-ray reveals a diffuse interstitial infiltrate. His temperature is 102 o F his CD4 count is 180. A bronchoscopy and transbronchial lung biopsy is performed

* other major causes of pulmonary infiltrates include mycobacterial infections, fungal infections, nonspecific interstitial pneumonitis, Kaposi’s Sarcoma, and lymphoma. * other major causes of pulmonary infiltrates include mycobacterial infections, fungal infections, nonspecific interstitial pneumonitis, Kaposi’s Sarcoma, and lymphoma. What are the most likely infectious agents causing this pneumonia? Parasitic - Pneumocystis carinii Bacterial –Streptococcal Pneumoniae,Hemophilus Influenza

What are the therapeutic options for each agent ? Pneumocystis Carinii is treated with First line Regimen 1. Trimethoprim/sulfamethoxazole (TMP/SMX) 15-20mg/kg/day of TMP and mg/kg/day of SMX 15-20mg/kg/day of TMP and mg/kg/day of SMX 2. Intravenous or IM Pentamidine for treatment of PCP. Aerosolized Pentamidine used for prophylaxis of PCP. Aerosolized Pentamidine used for prophylaxis of PCP. 300mg Pentamide per dose/day for 4 weeks 300mg Pentamide per dose/day for 4 weeks Alternative Regimens Dapsone/Trimethoprim- Dapsone 100mg Daily. Clindamycin/Primaquine- 600mg IV infusion, 15mg oral for 14 days. Pyrimethamine/ Folinic Acid -25mg twice a day, 3mg vitamin/day IM.

Streptococcus Pneumonia and Haemophilus Influenza Treatment ß-Lactam antibiotics, the cornerstone of therapy 1.Ceftriaxone or cefotaxime -2 g/day for 7 – 10 days. 2.Amoxycillin with sublactum of clauvinic acid- 2-3g/day IM or IV. 3.Newer Quinolones - Cipro,Gatifloxacin,500mg IV BID. 4.Vancomycin used only as last resort- 600mg IV /per day, slow administration. * Pneumonia caused by a penicillin-sensitive strain - 24 million units of penicillin. ** Rifampicin is used for chemoprophylaxis and carrier status eradication.

What are the most likely organisms causing the patients diarrhea? Parasitic -Cryptosporidia, Microsporidia and Isospora belli Fungal - Histoplasmosis, Coccidioidomycosis, and Penicilliosis Bacterial -Salmonella and Campylobacter Viral – CMV

What are the therapeutic options for these agents ? Parasitic Diarrhea 1.Therapy is predominantly supportive. 2.Albendazole, 400 mg bid, has been reported to be of benefit. 3.TMP/SMX thrice-weekly regimen, similar to prophylaxis against PCP. Fungal Diarrhea 1.Fluconazole -200mg /day oral. 2. Lipid -Amphotrecin- B, IV in severe cases.

Bacterial Diarrhea 1.Quinolones are mainstay- Ciprofloxaxin 500mg tid. 2.Azithromycin 1 g single dose as alternative regime. *Bismuth subsalicylate is an inexpensive agent for the prophylaxis of diarrhea Viral Diarrhea 1.Ganciclovir –IV 5-10mg per kg, slow infusion. 2.Foscarnet- 60mg/kg IV for upto 21 days for maintainence.